Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Dansk Kolinesterase Kartotek udreder patienter med forlænget paralyse efter suxamethon og mivacurium

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Multidisciplinær håndtering af svær jernforgiftning som følge af suicidalforsøg

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Oxygen under tryk som behandling

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Comparison between temporal and rectal temperature measurement

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Definition, pathology and pathogenesis of osteoarthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Definition, pathology and pathogenesis of osteoarthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Barriers and aidsto routine neuromuscular monitoring and consistent reversal practice: - a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reversal of mivacurium-induced neuromuscular blockade with a cholinesterase inhibitor: A systematic review

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Validation of subjective rating scales for assessment of surgical workspace during laparoscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The Danish Cholinesterase Research Unit (DCRU) is a nationwide unit for patients carrying mutations in the butyrylcholinesterase enzyme (BChE). BChE hydrolyzes the neuromuscular blocking drugs succinylcholine and mivacurium. Patients with mutations in the butyrylcholinesterase gene are at risk of experiencing a prolonged effect of the drugs, such as weakness or paralysis for hours. In order to diagnose the referred patients correctly, DCRU combines results such as BChE activity, genotyping, pedigree and clinical reactions to succinylcholine or mivacurium.

Translated title of the contributionDanish Cholinesterase Research Unit diagnoses patients with prolonged paralysis after succinylcholine and mivacurium
Original languageDanish
JournalUgeskrift for Laeger
Volume177
Issue number18
Pages (from-to)866-8
Number of pages3
ISSN0041-5782
Publication statusPublished - 27 Apr 2015

ID: 45903128